ArticleJAAD case reports2015
Combined biologic therapy for the treatment of psoriasis and psoriatic arthritis: A case report.
Article in JAAD case reports, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed, 28 citations in OpenAlex.
- Treatment of Juvenile Spondyloarthritis: Where We Stand.Paediatric drugs · 2020Trial
- Combination Treatment of IL-17 Inhibitor and JAK Inhibitor in Psoriatic Arthritis: A Case Report and Scoping Review.Immunity, inflammation and disease · 2026Article
- Dual biologic therapy in a patient with severe psoriasis and psoriatic arthritis, using guselkumab and bimekizumab: A case report and review of the literature.SAGE open medical case reports · 2026Article
- Retrospective Review on Safety and Efficacy of Combination Biologic Therapy for Psoriasis.The Australasian journal of dermatology · 2025Article
- Beyond Monotherapy: Exploring the Efficacy and Safety of Dual Biologic Strategies in Rheumatic Diseases.Biologics : targets & therapy · 2025Review
- Dual anti-cytokine biologic and/or targeted synthetic therapy combination in spondyloarthritis: a narrative review. Are we missing the opportunity for higher remission rates?Frontiers in medicine · 2025Review
- The use of dual biologic therapy for the management of recalcitrant psoriasis.JAAD case reports · 2024Article
- Dual Biologic Therapy in Patients with Rheumatoid Arthritis and Psoriatic Arthritis.Rambam Maimonides medical journal · 2023Review
- Dual targeted therapy in patients with psoriatic arthritis and spondyloarthritis: a real-world multicenter experience from Spain.Frontiers in immunology · 2023Article
- Dual Biologic Therapy in Patients with Familial Mediterranean Fever and Spondyloarthritis: Case-Based Review.European journal of rheumatology · 2023Article
- Latest combination therapies in psoriasis: Narrative review of the literature.Dermatologic therapy · 2022Review
- Treatment patterns and healthcare resource utilization in palmoplantar pustulosis patients in Japan: A claims database study.PloS one · 2020Article
- Dual biologic therapy for recalcitrant psoriasis and psoriatic arthritis.JAAD case reports · 2019Article
- Combination biologic therapy for the treatment of severe palmoplantar pustulosis.JAAD case reports · 2017Article
- Advanced Combination Therapy with Tofacitinib and Biologic Agents for Psoriasis and Psoriatic Arthritis: A Case Series.Case reports in dermatologyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 2 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.